Pharma Journalist -

Zymeworks Inc. announced that it has entered into a licensing agreement that grants Iconic Therapeutics, Inc. (Iconic) non-exclusive rights to Zymeworks’ proprietary ZymeLink…
Read More...

Hoth Therapeutics, announced that the company has signed a term sheet with Zylö Therapeutics Inc (Zylö) to co-develop a new treatment for patients suffering from Cutaneous Lupus…
Read More...

AbbVie announced that it has resolved U.S. HUMIRA (adalimumab) litigation with Boehringer Ingelheim (BI). Under the terms of the resolution, AbbVie will grant BI a non-exclusive license…
Read More...

SMi reports: Registration is now open for the HPAPI USA conference, taking place in Boston on the 21st - 22nd October 2019. The HPAPI global market is growing at an ever-increasing…
Read More...

Chairman of the 2019 Biosimilars Conference, Michel Mikhail, International Expert Regulatory Affairs, Global Expert of Biosimilars, invites biosimilar experts to attend the next…
Read More...

Exelixis, Inc. announced its partner Daiichi Sankyo Company, Limited has launched MINNEBRO (esaxerenone) tablets as a treatment for patients with hypertension in Japan. With Daiichi…
Read More...

ElevateBio announced operations to create and build a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and…
Read More...

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to POMALYST (pomalidomide) for the treatment of patients with…
Read More...

Geoff Smith from De Montford University will be speaking at SMi’s 7th Annual Lyophilisation Conference which will take place in London on 3rd – 4th June 2019. He will be speaking on the…
Read More...

  After the three successful ACI's European Prefilled Syringes Summit, we are pleased to inform you that the 4th edition will take place this month on the 9th & 10th October in…
Read More...